One of the most recent additions is a prostate massager that has some features we havent seen in competitor models
Recent analyses presented at the National Lipid Associations 2025 Scientific Sessions highlighted cardiovascular, renal, and metabolic gains from GLP1s that appear partly independent of the amount of weight loss
HMSC pretreated with Ex-4 or modified to express Exendin-4 (hMSC-Ex-4) showed reduced HO-induced apoptosis and increased phosphorylated AMPK levels, effects blocked by the AMPK inhibitor compound C [18]
In the mid-2000s, Novo Nordisk had developed a peptide called liraglutide that mimics the gut hormone glucagon-like peptide-1 (GLP-1), leading to antidiabetic effects and weight loss
Gormally J, Black S, Daston S, Rardin D
doi: 10.1001/jamapsychiatry.2024.4789, 64 HeppnerK